Journals / Diagnostic and Interventional Radiology / 2021 / Cilt: 27 - Sayı: 2

Small-diameter TIPS combined with splenic artery embolization in the management of refractory ascites in cirrhotic patients

Pages
232–237
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, 20% of subjects with 10 mm TIPS required TIPS reduction/closurecompared to 7% of subjects with 8 mm TIPS.CONCLUSIONWe found that 8 mm diameter TIPS provided similar ascites control compared to 10 mm TIPSregardless of splenic embolization.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEMaximally decreasing portal pressures with transjugular intrahepatic portosystemic shunt(TIPS) is associated with improved ascites control but also increased encephalopathy incidence.
📊
Key Findings & Data:Subjects underwent creation of 8 mm TIPS followed by proximal splenic artery embolization (group A, n=8), or of 8mm (group B, n=6) or 10 mm TIPS (group C, n=41) without splenic embolization.
💡
Conclusion & Impact:Overall, 20% of subjects with 10 mm TIPS required TIPS reduction/closurecompared to 7% of subjects with 8 mm TIPS.CONCLUSIONWe found that 8 mm diameter TIPS provided similar ascites control compared to 10 mm TIPSregardless of splenic embolization.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

PURPOSEMaximally decreasing portal pressures with transjugular intrahepatic portosystemic shunt(TIPS) is associated with improved ascites control but also increased encephalopathy incidence. Since splenic venous flow contributes to portal hypertension, we assessed if combining small-diameter TIPS with splenic artery embolization could improve ascites while minimizing encephalopathy.METHODSFifty-five patients underwent TIPS creation for refractory ascites. Subjects underwent creation of 8 mm TIPS followed by proximal splenic artery embolization (group A, n=8), or of 8mm (group B, n=6) or 10 mm TIPS (group C, n=41) without splenic embolization. Data wereretrospectively reviewed.RESULTSIn group A, median portosystemic gradient decreased from 19 mmHg to 9 mmHg after TIPS,and 8 mmHg after subsequent splenic artery embolization. In groups B and C, gradient decreased from 15 mmHg to 8 mmHg and 16 mmHg to 6 mmHg. All patients except for one ingroup A and two in C had greater than 50% reduction in the number of paracenteses in 3months. Any postprocedural encephalopathy incidence was 62%, 50%, 83% in groups A, B,and C, respectively. Overall, 20% of subjects with 10 mm TIPS required TIPS reduction/closurecompared to 7% of subjects with 8 mm TIPS.CONCLUSIONWe found that 8 mm diameter TIPS provided similar ascites control compared to 10 mm TIPSregardless of splenic embolization. While more patients with 10 mm TIPS required reduction/closure for severe encephalopathy, the study was underpowered for definitive assessment.Splenic embolization might have the potential to further decrease portosystemic gradientand ascites as an alternative to dilation of TIPS to 10 mm minimizing the risk of encephalopathy, but larger studies are warranted.

🔖

Cite This Article

FRENK, N. E., BOCHNAKOVA, T., GANGULİ, S., MERCALDO, N., ALLEGRETTİ, A. S., PRATT, D. S., YAMADA, K. (2021). Small-diameter TIPS combined with splenic artery embolization in the management of refractory ascites in cirrhotic patients. Diagnostic and Interventional Radiology, Cilt: 27 - Sayı: 2, 232–237. https://ajindex.com/articles/349946

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bureau C, Thabut D, Oberti F, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 2017; 152:157–163. [Crossref] 2. Gaba RC, Parvinian A, Casadaban LC, et al. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: A single institution case-control propensity score analysis. Clin Radiol 2015; 70:e51–e57. [Crossref] 3. Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: An updated meta-analysis. World J Gastroenterol 2014; 20:2704–2714. [Crossref] 4. Rowley MW, Choi M, Chen S, Hirsch K, Seetharam AB. Refractory hepatic encephalopathy after elective transjugular intrahepatic portosystemic shunt: risk factors and outcomes with revision. Cardiovasc Intervent Radiol 2018; 41:1765–1772. [Crossref] 5. Schepis F, Vizzutti F, Garcia-Tsao G, et al. Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis. Clin Gastroenterol Hepatol 2018; 16:1153– 1162. [Crossref] 6. Riggio O, Ridola L, Angeloni S, et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial. J Hepatol 2010; 53:267–272. [Crossref] 7. Morali GA, Sniderman KW, Deitel KM, et al. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol 1992; 16:249–250. [Crossref] 8. Burgos AC, Thornburg B. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: review and update of the literature. Semin Intervent Radiol 2018; 35:165– 168. [Crossref] 9. Pravisani R, Baccarani U, Adani G, et al. Splenic artery syndrome as a possible cause of late onset refractory ascites after liver transplantation: management with proximal splenic artery embolization. Transplant Proc 2016; 48:377–379. [Crossref] 10. Turco L, Garcia-Tsao G, Magnani I, et al. Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis. J Hepatol; 2018; 68:949–958. [Crossref] 11. Rössle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165–171. [Crossref] 12. Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clini